| Dimension | REVRCEL | Henry Meds |
|---|---|---|
| Primary scope | Longevity & metabolic, with GLP-1 | Weight loss & GLP-1 focus |
| Bloodwork integration | Quarterly, full panel | Limited |
| Clinician follow-up | Clinician review of each order | On request |
| Co-prescription with hormones / peptides | Yes | Limited |
The honest summary
Henry Meds is a high-throughput telehealth focused on compounded semaglutide and tirzepatide for weight loss. REVRCEL prescribes the same compounded GLP-1 medications, sourced from licensed compounding pharmacies, but alongside bloodwork — meaning a member's GLP-1 protocol is reviewed against quarterly bloodwork and integrated with hormone, peptide, and metabolic context. Members focused exclusively on weight loss may prefer Henry's volume-driven price; members who want their GLP-1 protocol read alongside testosterone, IGF-1, ApoB, and HbA1c are better matched to REVRCEL.
Sources
Henry Meds public siteComparison drawn from each competitor's public site as of 2026. Statements have not been evaluated by the FDA. REVRCEL does not disparage competing practices; differences reflect distinct care models.
